These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7412480)

  • 1. Effect of sensory stimuli on the activity of dopaminergic neurons: involvement of non-dopaminergic nigral neurons and striato-nigral pathways.
    Hommer DW; Bunney BS
    Life Sci; 1980 Aug; 27(5):377-86. PubMed ID: 7412480
    [No Abstract]   [Full Text] [Related]  

  • 2. d-Amphetamine-induced inhibition of central dopaminergic neurons: mediation by a striato-nigral feedback pathway.
    Bunney BS; Achajanian GK
    Science; 1976 Apr; 192(4237):391-3. PubMed ID: 1257777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of striato-nigral substance P in the regulation of the activity of the nigro-striatal dopaminergic neurons.
    Glowinski J; Michelot R; Chéramy A
    Adv Biochem Psychopharmacol; 1980; 22():51-62. PubMed ID: 6156583
    [No Abstract]   [Full Text] [Related]  

  • 4. Excitatory input from sensory motor cortex to neostriatum and its modification by conditioning stimulation of the substantia nigra.
    Hirata K; Yim CY; Mogenson GJ
    Brain Res; 1984 Oct; 321(1):1-8. PubMed ID: 6093925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway.
    Commissiong JW; Gentleman S; Neff NH
    Neuropharmacology; 1979 Jun; 18(6):565-8. PubMed ID: 481709
    [No Abstract]   [Full Text] [Related]  

  • 6. d-Amphetamine-induced depression of central dopamine neurons: evidence for mediation by both autoreceptors and a striato-nigral feedback pathway.
    Bunney BS; Aghajanian GK
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Oct; 304(3):255-61. PubMed ID: 714182
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulations of the activity of the nigrostriatal dopaminergic pathways by cortical, cerebellar, and sensory neuronal afferences.
    Glowinski J; Niecoullon A; Chéramy A
    Adv Biochem Psychopharmacol; 1978; 19():75-87. PubMed ID: 358788
    [No Abstract]   [Full Text] [Related]  

  • 8. Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.
    Kondo Y; Iwatsubo K
    Brain Res; 1980 Jan; 181(1):237-40. PubMed ID: 7350960
    [No Abstract]   [Full Text] [Related]  

  • 9. Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems.
    Hanson GR; Alphs L; Wolf W; Levine R; Lovenberg W
    J Pharmacol Exp Ther; 1981 Aug; 218(2):568-74. PubMed ID: 6166743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of nigral dopaminergic neurons after lesion of the neostriatum in rats.
    Doudet D; Gross C; Seal J; Bioulac B
    Brain Res; 1984 Jun; 302(1):45-55. PubMed ID: 6733505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
    Olianas MC; De Montis GM; Mulas G; Tagliamonte A
    Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
    [No Abstract]   [Full Text] [Related]  

  • 12. Dorsal raphé stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo.
    Trent F; Tepper JM
    Exp Brain Res; 1991; 84(3):620-30. PubMed ID: 1830848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-Amphetamine-induced inhibition of central dopaminergic neurons: direct effect or mediated by a striatonigral feedback pathway?
    Bunney BS; Aghajanian GK
    Adv Biochem Psychopharmacol; 1977; 16():577-82. PubMed ID: 883560
    [No Abstract]   [Full Text] [Related]  

  • 14. Lack of effect of cerebellectomy on ascending dopaminergic neurons in the rat brain.
    Lovell KL; Bruner CA; Moore KE
    Neurosci Lett; 1982 Oct; 32(2):187-92. PubMed ID: 7145238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the striato-nigral pathway responsible for 'feed-back' control of dopamine release [proceedings]?
    Arbuthnott GW; Garcia-Munoz M; Nicolaou NM; Tulloch IF; Wright AK
    Br J Pharmacol; 1976 Oct; 58(2):272P. PubMed ID: 974393
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of the activity of the two dopaminergic systems by cortical, cerebellar and sensory afferents in the cat.
    Nieoullon A; Chéramy A; Glowinski J
    Appl Neurophysiol; 1979; 42(1-2):51-3. PubMed ID: 453803
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of increases in impulse flow.
    Tepper JM; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):309-16. PubMed ID: 6089959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the subthalamic nucleus enhances the release of dopamine in the rat substantia nigra.
    Mintz I; Hammond C; Guibert B; Leviel V
    Brain Res; 1986 Jun; 376(2):406-8. PubMed ID: 3730844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways.
    Michelot R; Leviel V; Giorguieff-Chesselet MF; Chéramy A; Glowinski J
    Life Sci; 1979 Feb; 24(8):715-23. PubMed ID: 86931
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopaminergic mechanisms involved in the acute and chronic effect of amphetamine [proceedings].
    Groves PM
    Psychopharmacol Bull; 1977 Jan; 13(1):44-5. PubMed ID: 834819
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.